ask="25.44"
ask_size="2600"
average_daily_volume="10703"
bid="22.00"
bid_size="100"
book_value="0.00"
change="+0.07"
change_from_200_day_moving_average="-1.26"
change_from_50_day_moving_average="-0.29"
change_from_52_week_high="-4.03"
change_From_52_week_low="4.21"
change_in_percent="+0.33%"
close="22.44"
dividend_pay_date="1/4/2016"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="N/A"
ex_dividend_date="12/29/2015"
float_shares="N/A"
high="22.50"
high_52_weeks="26.47"
last_trade_date="1/5/2017"
last_trade_price="22.44"
last_trade_size="200"
last_trade_time="3:44pm"
low="22.24"
low_52_weeks="18.23"
market_capitalization="22.44B"
moving_average_200_day="23.70"
moving_average_50_day="22.73"
name="Loncar Cancer Immunotherapy ETF"
notes="N/A"
one_year_target_price="N/A"
open="22.27"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-5.31%"
percent_change_from_50_day_moving_average="-1.29%"
percent_change_from_52_week_high="-15.22%"
percent_change_from_52_week_low="+23.07%"
previous_close="22.37"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="1000000000"
short_ratio="0.00"
stock_exchange="NGM"
symbol="CNCR"
volume="6265"
weeks_range_52="18.23 - 26.47"
